The prestigious medical journal BMJ has published a damning investigative article on a crop of new diabetes drugs called “incretin therapies,” which include Byetta and Januvia.
The article mentions a number of studies that have been published in recent years, indicating a potential link between these drugs and a potentially deadly inflammation of the pancreas called pancreatitis, as well as pancreatic cancer. Byetta has also been linked to thyroid cancer.
But the ...
continue reading...
According to U.S. News and World Report, the Food and Drug Administration’s decision to reevaluate the diabetes drug Avandia is proving controversial, with some detractors accusing the agency of unnecessarily wasting taxpayer resources.
Avandia was once a top-selling medication for its manufacturer, GlaxoSmithKline. But a 2007 study concluded that it raised the risk of heart attack by more than 40 percent. As a result, the FDA imposed restrictions on Avandia in ...
continue reading...
A New York Times story about the link between certain diabetes drugs and pancreatic cancer, says that more than 100 lawsuits have been filed. According to the report, more than 575 plaintiffs around the country are claiming injury from Byetta, and more than 40 claim Januvia caused pancreatic cancer.
Meanwhile, Dr. Peter C. Butler, an internationally renowned diabetes expert who first sounded health warnings about the link is standing up to ...
continue reading...
A story in Men’s Journal explores the question of how people who use statins such as Lipitor should react to a recent study indicating that the cholesterol-lowering drugs may counteract the benefits of exercise.
The study in the Journal of the American College of Cardiology looked at a group of overweight, sedentary adults at risk of high cholesterol or high blood pressure. After a 12-week exercise program, a group of participants ...
continue reading...
A new study suggests that cholesterol-lowering drugs called statins, such as Pfizer’s Lipitor, may negate some of the fitness benefits of exercise.
A story in the New York Times says the study’s findings may present a tricky quandary where preventive health care is concerned. While statins are routinely prescribed for those with high cholesterol and other risk factors for heart disease, exercise is also generally recommended for warding off heart disease ...
continue reading...
The U.S. Food and Drug Administration is taking a second look at the diabetes drug Avandia, with an agency report already suggesting that the drug’s attendant risk of heart problems may not be as serious as reported.
The Philadelphia Inquirer reports that Avandia, originally approved in 1999, was once a blockbuster for GlaxoSmithKline. But a 2007 study published in the New England Journal of Medicine said the drug caused heart problems. ...
continue reading...
